Trichomonas vaginalis and HIV infection acquisition: a systematic review and meta-analysis

Objectives Trichomoniasis is the most prevalent curable STI globally, with the highest incidence and prevalence in sub-Saharan Africa (sSA). STIs have largely been associated with an increase in HIV acquisition. Our objective was to assess the existing literature available in English regarding the association of Trichomoniasis and HIV-1 acquisition. Methods The review protocol was registered at the International Prospective Register of Systematic Reviews (PROSPERO) under number CRD42018082702. We searched MEDLINE, Embase and Scopus databases to collect articles measuring the association of Trichomonas vaginalis infection and HIV acquisition and performed a meta-analysis and qualitative synthesis of the literature. Results We identified 1806 unduplicated citations, of which 18 papers and 1 conference abstract were eligible for inclusion in the review after applying our inclusion and exclusion criteria. All the studies included in the systematic review had been carried out in sSA. The articles reported various measures of effects, namely: HRs, rate ratios, risk ratios and ORs. In a meta-analysis restricted to 11 studies reporting HR, individuals infected with T. vaginalis were 1.5 times more likely to acquire HIV compared with individuals not infected with T. vaginalis (95% CI 1.3 to 1.7; p<0.001). Conclusions T. vaginalis is an important factor in HIV acquisition especially in sSA where the prevalence of both T. vaginalis and HIV-1 are high. This systematic review and meta-analysis confirms the evidence that infection with T. vaginalis augments HIV acquisition with 50%. Diagnosis and treatment of T. vaginalis infection in both high-risk and low-risk individuals may be a potential tool to reduce new HIV infections. Trial registration number CRD42018082702

[1]  J. H. van de Wijgert,et al.  Role of HIV exposure and infection in relation to neonatal GBS disease and rectovaginal GBS carriage: a systematic review and meta-analysis , 2017, Scientific Reports.

[2]  Marleen Temmerman,et al.  Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting , 2015, PloS one.

[3]  Alison L. Drake,et al.  HIV acquisition during pregnancy and postpartum is associated with genital infections and partnership characteristics , 2015, AIDS.

[4]  J. Baeten,et al.  Changes in the contribution of genital tract infections to HIV acquisition among Kenyan high-risk women from 1993 to 2012 , 2015, AIDS.

[5]  Xian-tao Zeng,et al.  The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta‐analysis, and clinical practice guideline: a systematic review , 2015, Journal of evidence-based medicine.

[6]  P. Kissinger,et al.  Trichomoniasis and HIV interactions: a review , 2013, Sexually Transmitted Infections.

[7]  R. Hayes,et al.  Alcohol Use, Mycoplasma genitalium, and Other STIs Associated With HIV Incidence Among Women at High Risk in Kampala, Uganda , 2013, Journal of acquired immune deficiency syndromes.

[8]  J. Overbaugh,et al.  A prospective study of vaginal trichomoniasis and HIV-1 shedding in women on antiretroviral therapy , 2011, BMC infectious diseases.

[9]  S. Delany-Moretlwe,et al.  P1-S5.14 Risk factors associated with HIV acquisition: a comparative analysis of older and younger women who participated in the MDP301 trial in Johannesburg , 2011, Sexually Transmitted Infections.

[10]  G. Ramjee,et al.  Epidemiological Synergy of Trichomonas vaginalis and HIV in Zimbabwean and South African Women , 2010, Sexually transmitted diseases.

[11]  D. Moher,et al.  Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement , 2009, BMJ : British Medical Journal.

[12]  C. Morrison,et al.  Disentangling Contributions of Reproductive Tract Infections to HIV Acquisition in African Women , 2009, Sexually transmitted diseases.

[13]  T. Farley,et al.  Trichomonas Vaginalis Treatment Reduces Vaginal HIV-1 Shedding , 2009, Sexually transmitted diseases.

[14]  C. Morrison,et al.  Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women. , 2008, The Journal of infectious diseases.

[15]  I. Kleinschmidt,et al.  Injectable progestin contraceptive use and risk of HIV infection in a South African family planning cohort. , 2007, Contraception.

[16]  J. Baeten,et al.  Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition. , 2007, The Journal of infectious diseases.

[17]  J. Baeten,et al.  Re: distinguishing the temporal association between women's intravaginal practices and risk of human immunodeficiency virus infection: a prospective study of South African women. , 2006, American journal of epidemiology.

[18]  W. Miller,et al.  The Cost-Effectiveness of Treating Male Trichomoniasis to Avert HIV Transmission in Men Seeking Sexually Transmitted Disease Care in Malawi , 2006, Journal of acquired immune deficiency syndromes.

[19]  A. Ouedraogo,et al.  Is Sexually Transmitted Infection Management Among Sex Workers Still Able to Mitigate the Spread of HIV Infection in West Africa? , 2005, Journal of acquired immune deficiency syndromes.

[20]  J. Baeten,et al.  Contribution of HIV-1 infection to acquisition of sexually transmitted disease: a 10-year prospective study. , 2005, The Journal of infectious diseases.

[21]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[22]  S. Kennedy,et al.  Candida infection as a risk factor for HIV transmission. , 2003, Journal of women's health.

[23]  G. Satten,et al.  Effect of interventions to control sexually transmitted disease on the incidence of HIV infection in female sex workers , 2001, AIDS.

[24]  T. Quinn,et al.  Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. , 2000, The New England journal of medicine.

[25]  B. Richardson,et al.  Hormonal contraception, sexually transmitted diseases, and risk of heterosexual transmission of human immunodeficiency virus type 1. , 1998, The Journal of infectious diseases.

[26]  D R Hoover,et al.  Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV , 1998, AIDS.

[27]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[28]  P. Piot,et al.  Condom promotion, sexually transmitted diseases treatment, and declining incidence of HIV-1 infection in female Zairian sex workers , 1994, The Lancet.

[29]  H. Leix.  [The treatment of trichomoniasis in women]. , 1972, Therapie der Gegenwart.

[30]  P. Kissinger,et al.  Single-Dose Compared With Multidose Metronidazole for the Treatment of Trichomoniasis in Women: A Meta-Analysis , 2017, Sexually transmitted diseases.

[31]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2009, Journal of clinical epidemiology.

[32]  L. Myer,et al.  Distinguishing the temporal association between women's intravaginal practices and risk of human immunodeficiency virus infection: a prospective study of South African women. , 2006, American journal of epidemiology.

[33]  M. Laga,et al.  Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. , 1993, AIDS.